000 | 01878na a2200241 4500 | ||
---|---|---|---|
999 |
_c3484 _d3484 |
||
003 | H12O | ||
005 | 20190820130226.0 | ||
008 | 130622s2012 xxx||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_983 _aMorales Ruiz, Enrique _eNefrología |
||
100 |
_aPraga Terente, Manuel _91488 _eNefrología |
||
245 | 0 | 4 |
_aThe effect of weight loss in obesity and chronic kidney disease. _h[artículo] |
260 |
_bCurrent Hypertension Reports, _c2012 |
||
300 | _a14(2):170-6. | ||
500 | _aFormato Vancouver: Morales E, Praga M. The effect of weight loss in obesity and chronic kidney disease. Curr Hypertens Rep. 2012 Apr;14(2):170-6. | ||
501 | _aPMID: 22258314 | ||
504 | _aContiene 51 referencias | ||
520 | _aSeveral epidemiologic investigations have confirmed that obesity is a significant risk factor for the appearance of proteinuria and end-stage kidney disease in a normal population. Weight loss induced by low-calorie diets, physical exercise, or bariatric surgery is accompanied by an important antiproteinuric effect. Reduction in proteinuria is already observed after a few weeks from the onset of weight loss and it is evident even in patients with modest weight losses. Reduction in proteinuria by weight loss has been described in chronic proteinuric nephropathies of different etiologies. The mechanisms through which weight loss may reverse proteinuria are likely to be plural: better control of blood pressure, improvement of serum lipid profile, improvement of insulin sensitivity, better glycemic control in diabetes patients, decrease of circulating leptin levels, reversal of glomerular hyperfiltration, and decreased activation of the renin-angiotensin-aldosterone system. | ||
710 |
_986 _aServicio de Nefrología |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/3/pc3484.pdf _ySolicitar documento |
||
942 |
_n0 _2ddc _cART |